What does the evidence say about Algae-Oil-Triglycerides-Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Algae-Oil-Triglycerides-Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Background: Supplementation with long-chain omega-3 polyunsaturated fatty acids (LC n -3 PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may mitigate exercise-induced muscle damage (EIMD) and enhance post-exercise recovery. [Yaghoobi E (2026); evidence level 1] - However, the systematic reviews/meta-analyses evaluating these effects across populations and exercise models are limited and do not provide dosing recommendations. [Yaghoobi E (2026); evidence level 1] - Conclusion In adults with HIV, omega-3 supplementation was associated with small, insignificant increases in HDL-C and meaningful reductions in triglycerides, whereas effects on other lipid fractions were inconsistent. [Bai J (2026); evidence level 1] - Omega-3 supplementation was associated with a consistent reduction in CRP and modest improvements in other inflammatory biomarkers such as IL-6, while evidence for TNF- α remains inconclusive. [Bai J (2026); evidence level 1] - Background People living with human immunodeficiency virus (HIV) infection frequently exhibit altered lipid profiles and persistent inflammation that contribute to long-term morbidity. [Bai J (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.